Literature DB >> 12498010

Pitavastatin Nissan/Kowa Yakuhin/Novartis/Sankyo.

Nicholas A Flores1.   

Abstract

Pitavastatin (nisvastatin) is an HMG CoA reductase inhibitor being developed jointly by Nissan, Kowa Kogyo, Novartis and Sankyo for the potential treatment of atherosclerosis and hyperlipidemia.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12498010

Source DB:  PubMed          Journal:  Curr Opin Investig Drugs        ISSN: 1472-4472


  1 in total

1.  Pitavastatin: evidence for its place in treatment of hypercholesterolemia.

Authors:  Peter Alagona
Journal:  Core Evid       Date:  2010-10-22
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.